Legacy Pharmaceutical Sertraline Tablets Recall: Risk of Product Contamination
Legacy Pharmaceutical Packaging LLC recalls Sertraline 100mg tablets (NDC 68645-523-54) due to potential product contamination from inadequate line clearance during manufacturing. Affected lots may have mixed products.
Lower-risk recall
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
Contact the company
What happened, in plain English
Legacy Pharmaceutical Packaging LLC is recalling Sertraline 100mg tablets that could have been contaminated during manufacturing. This recall affects people who took these specific tablets and may require checking their medication labels. Read more at govinfonow.com/recall/32929-legacy-pharmaceutical-sertraline-tablets-recall-risk-of-product-contamination.
Source Summary by GovInfoNow · govinfonow.com/recall/32929-legacy-pharmaceutical-sertraline-tablets-recall-risk-of-product-contamination · Updated August 17, 2026 · FDA enforcement record: FDA #D-0205-2024
Cite this page
“Legacy Pharmaceutical Sertraline Tablets Recall: Risk of Product Contamination.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32929-legacy-pharmaceutical-sertraline-tablets-recall-risk-of-product-contamination. Based on FDA recall #D-0205-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0205-2024%22&limit=1).
Why it’s dangerous
Inadequate line clearance during manufacturing could cause product contamination. This means some tablets might have mixed with other products, potentially affecting safety.
Who’s affected
People who purchased Sertraline 100mg tablets with the NDC code 68645-523-54 from Wal-Mart stores in Bentonville, AR. Those with mental health conditions requiring this medication are most at risk.
How to tell if you have this one
Check for the NDC code 68645-523-54 on the bottle label. The lot number is 222033 with an expiration date of August 31, 2024.
- Brand
Legacy Pharmaceutical Packaging LLC- Category
Drug
What to do — step by step
Check Medication Label
Look for the NDC code 68645-523-54 and lot number 222033 on the bottle.
Where it went and when
Where it was distributed
Distributed in Arkansas and California.
FDA distribution: “CA and AR” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Arkansas, California.
Recall timeline
FDA published this recall 23 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this recall dangerous?
The recall is for potential product contamination due to manufacturing issues, but no injuries have been reported.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0205-2024 (December 11, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0205-2024 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.